-
+22 +1
Making RNA vaccines easier to swallow
Like most vaccines, RNA vaccines have to be injected, which can be an obstacle for people who fear needles. Now, a team of MIT researchers has developed a way to deliver RNA in a capsule that can be swallowed, which they hope could help make people more receptive to them.
-
+19 +1
COVID vaccine markedly cuts household transmission, studies show
A pair of studies in yesterday in Science show the substantial benefit of COVID-19 vaccination to household contacts in Israel, including unvaccinated children. But one of the studies highlighted waning protection over time.
-
+14 +1
Moderna launches clinical trial for HIV vaccine that uses mRNA technology
Moderna announced Thursday that it's launched early-stage clinical trials of an HIV mRNA vaccine. The biotechnology company has teamed up with the nonprofit International AIDS Vaccine Initiative to develop the shot, which uses the same technology as Moderna's successful COVID-19 vaccine.
-
+2 +1
COVID-19: Moderna vaccine may reduce infection risk more than Pfizer
The COVID-19 vaccines from Moderna and Pfizer are messenger ribonucleic acid (mRNA) vaccines, a relatively new form of vaccine technology. COVID-19 vaccines work by giving our cells instructions on making a SARS-CoV-2 protein. Our immune system reacts to these proteins and creates the necessary tools to deal with any future virus infection.
-
+13 +1
Howard Stern Urges Meat Loaf’s Family to Speak Out on COVID Vaccine After His Death
Howard Stern is calling on Meat Loaf’s family to speak out on vaccines following the rock icon’s death earlier this month. Meat Loaf died Jan. 20. TMZ reported at the time that the singer had been “seriously ill with COVID” and that “his condition quickly became critical.” It’s unknown at this time whether or not Meat Loaf was vaccinated against COVID.
-
+21 +1
‘Nocebo effect’: two-thirds of Covid jab reactions not caused by vaccine, study suggests
More than two-thirds of the common side-effects people experience after a Covid jab can be attributed to a negative version of the placebo effect rather than the vaccine itself, researchers claim. Scientists in the US examined data from 12 clinical trials of Covid vaccines and found that the “nocebo effect” accounted for about 76% of all common adverse reactions after the first dose and nearly 52% after the second dose.
-
+17 +1
Pregnant people are still not getting vaccinated against Covid
Calendar year three into the pandemic, and vaccination coverage among pregnant people remains staggeringly low. According to data from the US Centers for Disease Control and Prevention, as of January 1, just over 40 percent of pregnant people in the United States between age 18 and 49 were fully vaccinated prior to pregnancy or during their pregnancy, compared with 66 percent of the general population over the age of 5. For Black pregnant people, the figure plummets to about 25 percent. Data for the United Kingdom is a little less up to date, but in August 2021 just 22 percent of women who gave birth were fully vaccinated.
-
+20 +1
Texas scientists’ new Covid-19 vaccine is cheaper, easier to make and patent-free
A new Covid-19 vaccine is being developed by Texas scientists using a decades-old conventional method that will make the production and distribution cheaper and more accessible for countries most affected by the pandemic and where new variants are likely to originate due to low inoculation rates.
-
+18 +1
mRNA vaccine technology has helped repair broken hearts in mice
Immune cells in the bodies of mice have been temporarily reprogrammed to repair damaged hearts by removing scar tissue, thanks to the technology used in the mRNA coronavirus vaccines. “After you give the treatment, the scar goes away,” says Haig Aghajanian at the University of Pennsylvania.
-
+22 +1
A new coronavirus vaccine heading to India was developed by a small team in Texas. It expects nothing in return.
The ambition is to create a low-cost, open-source alternative to expensive and limited supply mRNA vaccines for developing and under-vaccinated countries.
-
+13 +1
New patent-free COVID vaccine developed as “gift to the world”
A new COVID-19 vaccine, developed by researchers from the Texas Children’s Hospital and Baylor College of Medicine, is being offered patent-free to vaccine manufacturers across the world. Human trials have shown the vaccine to be safe and effective, with India already authorizing its use as production ramps up to over 100 million doses per month.
-
+21 +1
Vaccine effect fades faster for cancer patients; boosters restore it
Vaccine protection against COVID-19 wanes more quickly among cancer patients, but boosters rapidly bolster their antibody levels, Israeli research has found. The study supports the case for giving cancer patients third vaccine doses in countries where they have only received two, according to author Dr. Hagai Ligumsky. And it encourages the rollout of fourth shots for this demographic in countries like Israel that already gave third shots, he added.
-
+17 +1
Cambridge needle-free coronavirus vaccine enters clinical trial
Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive the vaccine today at the NIHR Southampton Clinical Research Facility.
-
+19 +1
These are the viruses that mRNA vaccines may take on next
Now that mRNA vaccines have proved effective against the coronavirus, scientists are taking aim at influenza, HIV and other viruses.
-
+14 +1
Billie Eilish: I would have died from Covid-19 if I hadn’t been vaccinated
The pop star told Howard Stern that she had the virus in August: ‘I want it to be clear that it is because of the vaccine I’m fine’
-
+20 +1
Survey: 59% think too many people are using religion to avoid vaccine
Several people remain unconvinced that religious exemptions for COVID-19 vaccines are necessary.
-
+18 +1
Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study
A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.
-
+4 +1
Scientists may have solved an important part of the mystery of ultra-rare blood clots linked to adenovirus COVID-19 vaccines
An international team of scientists believe they may have found a molecular mechanism behind the extremely rare blood clots linked to adenovirus COVID-19 vaccines. Scientists from Cardiff University and Arizona State University worked with AstraZeneca to investigate vaccine-induced immune thrombotic thrombocytopenia (VITT), also known as thrombosis with thrombocytopenia syndrome (TTS), a life-threatening condition seen in a very small number of people after receiving the Oxford-AstraZeneca or Johnson & Johnson vaccines.
-
+25 +1
Could mRNA make us superhuman?
Scientists believe mRNA vaccines – which have played a crucial role in our fight against Covid-19 – could solve a number of health issues for humans.
-
+26 +1
Age, sex and waning COVID-19 antibodies
Antibody levels after COVID-19 vaccination vary by age and sex, but across the board, antibody levels dropped significantly within six months. As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.
Submit a link
Start a discussion